Skip to main content
. 2015 Oct 5;6:8437. doi: 10.1038/ncomms9437

Figure 7. Eomes+CD4+ T cells from SPMS patients have characteristics of cytotoxic cells.

Figure 7

(a) PBMCs from SPMS patients were cultured with or without anti-CD3 and anti-CD28 antibodies in the presence of fluorescently conjugated anti-CD107a antibodies and brefaldin A. After 5 h stimulation, cells were then stained intracellularly for expression of Eomes. Plots show CD107a surface trapping for unstimulated (left) and restimulated (right) for CD3+CD4+ T cells and granzyme B, and perforin 1 staining shown in b. (c) PBMCs from SPMS patients were stimulated with PMA/ionomycin in the presence of GolgiPlug. After 5 h stimulation, cells were stained intracellularly with antibodies against granzyme B, IFN-γ, IL-17 and IL-10. Plots show CD3+CD4+ PBMCs from a representative SPMS patient from four SPMS patients tested.